1. Home
  2. TCRX vs ASTC Comparison

TCRX vs ASTC Comparison

Compare TCRX & ASTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TScan Therapeutics Inc.

TCRX

TScan Therapeutics Inc.

SELL

Current Price

$0.14

Market Cap

11.8M

Sector

Health Care

ML Signal

SELL

Logo Astrotech Corporation (DE)

ASTC

Astrotech Corporation (DE)

HOLD

Current Price

$3.51

Market Cap

10.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCRX
ASTC
Founded
2018
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
11.8M
10.5M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
TCRX
ASTC
Price
$0.14
$3.51
Analyst Decision
Hold
Analyst Count
5
0
Target Price
★ $1.00
N/A
AVG Volume (30 Days)
★ 420.2K
17.3K
Earning Date
11-12-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
12.28
★ 2600.00
EPS
N/A
★ 0.25
Revenue
★ $10,325,000.00
$1,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$14.32
Revenue Growth
★ 266.65
N/A
52 Week Low
$0.14
$1.92
52 Week High
$1.47
$68.85

Technical Indicators

Market Signals
Indicator
TCRX
ASTC
Relative Strength Index (RSI) 31.39 26.15
Support Level N/A $2.14
Resistance Level $0.21 $3.76
Average True Range (ATR) 0.02 0.34
MACD 0.00 -0.01
Stochastic Oscillator 8.07 7.01

Price Performance

Historical Comparison
TCRX
ASTC

About TCRX TScan Therapeutics Inc.

TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.

About ASTC Astrotech Corporation (DE)

Astrotech Corp is a science and technology company. It creates, operates and scales businesses through its subsidiaries and technology platforms, including space-related technology, instrumentation, mass spectrometry, gas chromatography, process-control and environmental analysis technologies. It is evaluating opportunities to identify, develop and commercialize technologies with potential applications in space, defense, industrial, environmental, quantum computing, AI, semiconductor materials, lunar infrastructure and related markets. Its products include Tracer 1000 ETD, tracer 1000 NTD, Labrador HHGC, Fenceline GC, AgLab 1000-D2, among others. It operates in single segment.

Share on Social Networks: